Differentiating hemodynamic compromise by the OEF response to acetazolamide in occlusive vascular disease

Advances in Experimental Medicine and Biology

Volumn 566, Issue , 2005, Pages 135-141

  Nemoto, Edwin M ^a   Yonas, Howard ^a   Kuwabara, Hiroto ^a   Pindzola, Ronda ^a   Sashin, Donald ^a   Chang, Yuefang ^a   Jovin, Tudor ^a   Gebel, James ^a   Hammer, Maxim D ^a   Wechsler, Lawrence ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACETAZOLAMIDE; OXYGEN;

ADULT; AGED; BRAIN BLOOD FLOW; CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; EXTRACTION; FEMALE; HEMODYNAMICS; HUMAN; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PRIORITY JOURNAL; TRANSIENT ISCHEMIC ATTACK;

ACETAZOLAMIDE; ADULT; AGED; ARTERIAL OCCLUSIVE DISEASES; CEREBROVASCULAR ACCIDENT; FEMALE; HEMODYNAMIC PROCESSES; HUMANS; ISCHEMIC ATTACK, TRANSIENT; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; OXYGEN; POSITRON-EMISSION TOMOGRAPHY; RISK FACTORS;

EID: 33646892412     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/0-387-26206-7_19     Document Type: Conference Paper

References (11)

1. E. M. Nemoto, H. Yonas, H. Kuwabara, R. Pindzola, D. Sashin, C. C. Meltzer, J. C. Price, and Y. F. Change, Detection of stage II compromised cerebrovascular reserve by Xenon-CT cerebral blood flow with acetazolamide and oxygen extraction fraction by positron emission tomography, in: Brain Imaging Using PET, edited by M. Senda, Y. Kimura, and P. Herscovitch (Academic Press, New York, 2002), pp. 259-267.
2. R. P. Woods, S. R. Cherry, and J. C. Mazziotta, Rapid automated algorithm for aligning and reslicing PET images, J. Comp. Assist. Tomog. 16, 620-633 (1992).
3. 15O] water clearance in humans determined by PET: I. Theory and normal values, J. Cereb. Blood Flow Metab. 16, 765-780 (1966).
4. 15O autoradiography and positron emission tomography with respect to the dispersion of the input function, J. Cereb. Blood Flow Metab. 6, 536-545 (1986).
5. M. A. Mintun, M. E. Raichle, W. R. Martin, and P. Herscovitch, Brain oxygen utilization measured with O-15 radiotracers and positron emission tomography, J. Nucl. Med. 25, 177-187 (1983).
6. S. Ohta, E. Meyer, and C. J. Thompson, Oxygen consumption of the living human brain measured after a single inhalation of positron emitting oxygen, J. Cereb. Blood Flow Metab. 12, 179-192 (1992).
7. E. M. Nemoto, H. Yonas, H. Kuwabara, R. R. Pindzola, D. Sashin, C. C. Meltzer, J. C. Price, Y. Chang, and D. W. Johnson, Identification of hemodynamic compromise by CVR and OEF in occlusive vascular disease, J. Cereb. Blood Flow Metab. (In press, October 2004).
8. 2 responsiveness measured by positron emission tomography, J. Cereb. Blood Flow Metab. 8(2), 227-235 (1988).
9. T. Nariai, R. Suzuki, K. Hirakawa, T. Maehara, K. Ishii, and M. Senda, Vascular reserve in chronic cerebral ischemia measured by the acetazolamide challenge test: comparison with positron emission tomography, Am. J. Neuroradiol. 16(3), 563-570 (1995).
10. 123I-iodoamphetamine single-photon emission computed tomography in patients with carotid occlusive diseases, Stroke 33(9), 2217-2223 (2002).
11. H. Yamauchi, H. Fukuyama, Y. Nagahama, H. Nabatame, M. Ueno, S. Nishizawa, J. Konishi, and H. Shio, Significance of increased oxygen extraction fraction in five-year prognosis of major cerebral arterial occlusive diseases, J. Nucl. Med. 40, 1992-1998 (1999).